Directs the commissioner of health, in conjunction with the commissioners of mental health and veterans' services, to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder, and the increasing rate of PTSD diagnoses in veterans and first responders.
STATE OF NEW YORK
________________________________________________________________________
4664
2025-2026 Regular Sessions
IN SENATE
February 11, 2025
___________
Introduced by Sens. ASHBY, FERNANDEZ -- read twice and ordered printed,
and when printed to be committed to the Committee on Health
AN ACT in relation to to directing the commissioner of health to conduct
a study on the use of ibogaine as a treatment for post-traumatic
stress disorder
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. 1. The commissioner of health, in conjunction with the
2 commissioner of mental health and the commissioner of veterans'
3 services, is authorized and directed to conduct a study to research the
4 use of ibogaine as a treatment for post-traumatic stress disorder and
5 the increasing rate of diagnoses of post-traumatic stress disorder in
6 veterans and first responders.
7 2. The study conducted pursuant to subdivision 1 of this section shall
8 examine any possible benefits and risks, and the appropriateness and
9 effectiveness of ibogaine as a treatment for post-traumatic stress
10 disorder.
11 3. The commissioner of health shall submit a report on the findings of
12 the study conducted pursuant to subdivision 1 of this section, and
13 recommendations, to the governor, the speaker of the assembly, the
14 temporary president of the senate, the minority leader of the senate,
15 the minority leader of the assembly and all members of each house of the
16 New York state legislature no later than one year following the effec-
17 tive date of this act.
18 § 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD08935-01-5
